ESTUDIO PROSPECTIVO SOBRE LA TASA DE DETECCIÓN DE CÁNCER DE PRÓSTATA EN NUESTRO HOSPITAL EN PACIENTES DEL NORESTE DE MÉXICO CON ANTÍGENO PROSTÁTICO ESPECÍFICO ENTRE 2.6 Y 4 NG/ML

Jorge A. Arratia-Maqueo, Jeff R. Cortés-González, Roberto Garza-Cortes, Lauro S. Gómez-Guerra

PDF(178 KB)
AEU
Archivos Españoles de Urología ›› 2010, Vol. 63 ›› Issue (4) : 287-290. DOI: 10.4321/S0004-06142010000400007
Article

ESTUDIO PROSPECTIVO SOBRE LA TASA DE DETECCIÓN DE CÁNCER DE PRÓSTATA EN NUESTRO HOSPITAL EN PACIENTES DEL NORESTE DE MÉXICO CON ANTÍGENO PROSTÁTICO ESPECÍFICO ENTRE 2.6 Y 4 NG/ML

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2010, 63(4): 287-290 https://doi.org/10.4321/S0004-06142010000400007

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
Article Options
  • PDF (9 views)
  • Full Text ( views)

Accesses

Citation

Detail
Sections
Recommended

Journal Info

About AEU
Indexing & Archiving
Editorial Board
Open Access
Copyright & License

For Authors

Submit
Instructions for Authors
Editorial Process
Article Processing Charge

For Reviewers

Online Review
Guidelines for Reviewers
Peer Review Process
Reviewer Board

Articles

Current Issue
Archives
Follow Us on
Copyright © 2023.
  • Disclaimer
    The statements, opinions and data contained in Archivos Españoles de Urología are solely those of the individual authors and contributors and not of the journal and the editor(s). Archivos Españoles de Urología stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.
    • 　　Terms & Conditions　　 Terms & Use　　　 Privacy Policy　

    /

    〈 〉